跳至主要内容
临床试验/JPRN-UMIN000032027
JPRN-UMIN000032027招募中未知

Elucidation of the pathophysiological mechanism of dementia and clinical research for creation of drug discovery targets - Elucidation of the pathophysiological mechanism of dementia

Keio University, School of Medicine0 个研究点目标入组 500 人开始时间: 2018年3月31日最近更新:

试验速览

阶段
未知
状态
招募中
入组人数
500

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. When a cerebral infarction or a local lesion which affects infection or cognitive function is found by MRI at screening. Small infarcts in the deep area and diffuse changes in the white matter allow incorporation except those occurring in specific sites affecting cognitive function, but in principle cortical infarction is excluded. 2. There is a problem to take a MRI imaging due to pacemaker, aneurysm clip, artificial valve, cochlear implant or other magnetic or electrically conductive metal, or claustrophobia. 3. If you have psychiatric symptoms, excitability, behavior abnormalities that make it difficult to follow the protocol within the past 3 months. 4. When suffering from severe systemic disease or unstable disease. 5. There are abnormalities affecting cognitive function in vitamin B 12 deficiency, syphilis, thyroid function. 6. When performing lumbar puncture, if you are taking antiplatelet medications, take the following drug withdrawal period into consideration before the examination. 7. Subject is participating in any treatment drug trials. 8. It is clear that participation in clinical trials of Alzheimer's disease treatment drug is made during the 3-year research period. 9. When taking a combination prohibited medicine such as warfarin. 10. Huntington's disease, multiple cerebral infarction, normal pressure hydrocephalus, brain tumor, epilepsy, paroxysmal disease, subdural hematoma, multiple sclerosis. 11. When there is a history of juvenile onset normal schizophrenia. 12. It is judged by the attending physician not to be appropriate.

研究者

相似试验